No Prescription |
 |
 | ||
|
Xalatan Generic Latanoprost |
|
| ||
No Prescription » Prescription Drugs 17 » Xalatan Generic Latanoprost Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Xalatan is used for: Treating increased pressure in the eye (ocular hypertension) and open-angle glaucoma. Latanoprost ophthalmic reduces pressure in the eye by increasing the amount of fluid that drains from the eye. Latanoprost ophthalmic is used to treat glaucoma and high pressure in the eye(s). Latanoprost (la-TA-noe-prost) is used to treat certain kinds of glaucoma. It is also used to treat a condition called hypertension of the eye. Latanoprost appears to work by increasing the outflow of fluid from the eye. This lowers the pressure in the eye. Buy Xalatan Generic Latanoprost and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Xalatan Generic Latanoprost: Product Type: Prescription Drugs 17 Xalatan ( Generic Latanoprost ) Xalatan (Generic Latanoprost) Generic Latanoprost 0.01% Generic Latanoprost Xalatan
View more Prescription Drugs 17 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
